Identification of a nine-gene immune signature that predicts efficacy of cyclin-dependent kinase 4/6 inhibitor (CDK4/6i) treatment in first-line patients. Credit:...
Key
Dublin, June 04, 2025 (GLOBE NEWSWIRE) -- The "Oncology Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025-2034" report...
When you receive a breast cancer diagnosis, it’s natural to have a lot of questions — including, “Should I get...
This review highlights the critical role of ubiquitination in governing the functionality of cancer stem cells (CSCs), shedding light on...
A new research paper was published in Oncotarget, Volume 16, on February 18, 2025, titled "Robust p53 phenotypes and prospective downstream targets...
An interprofessional QHS research study is tackling healthcare staffing challenges to strengthen Ontario’s integrated care system In 2019, Ontario introduced...
